반응식
[Cl:1][C:2]1[CH:7]=[C:6]([Cl:8])[CH:5]=[CH:4][C:3]=1[C:9]1[N:10]=[C:11]([CH2:28][CH3:29])[C:12]([NH:17][C@@H]2C3C(=CC=CC=3)C[C@@H]2O)=[N:13][C:14]=1[CH2:15][CH3:16].C(C1C(N[CH:41]2[C:46]3[CH:47]=[CH:48][O:49][C:45]=3[CH2:44][CH2:43][CH2:42]2)=NC(CC)=CN=1)C>>[Cl:1][C:2]1[CH:7]=[C:6]([Cl:8])[CH:5]=[CH:4][C:3]=1[C:9]1[N:10]=[C:11]([CH2:28][CH3:29])[C:12]([NH:17][CH:41]2[C:46]3[CH:47]=[CH:48][O:49][C:45]=3[CH2:44][CH2:43][CH2:42]2)=[N:13][C:14]=1[CH2:15][CH3:16]참가 물질
3
실험 절차
Following the procedure for the preparation of (1R,2S)-1-{[5-(2,4-dichlorophenyl)-3,6-diethylpyrazin-2-yl]amino}-2,3-dihydro-1H-inden-2-ol but substituting 3,6-diethyl-N-(4,5,6,7-tetrahydro-1-benzofuran-4-yl)pyrazin-2-amine and making non-critical variations provided the title compound as a oil: 1H NMR (400 MHz, CDCl3) δ 7.50, 7.34, 5.30, 4.53, 2.68, 2.62, 2.51, 2.09, 1.94 1.26, 1.20; HRMS (EI) calcd for C22H23Cl2N3O 415.1218, found 415.1217.
출처 및 근거
- ORD 기록
- ord-777573bfca3b455ea3f41352e8df7041
- 출처 데이터셋
- uspto-grants-2006_01
- 특허 번호
- US06992087B2
연결된 노트
불러오는 중…